Bikam Pharmaceuticals

Small molecule therapeutics for degenerative eye diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2007 language bikampharmaceuticals.com

Innovation

9 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 940 times.

YearFilings
20123
20134
20145
20156
20164
20176
20185
20193
20201

Investor mix

4 investors on record; lead investors include CHL Medical Partners, Healthcare Ventures; 1 has since exited.

Investor typeCountShare
Venture capital4100%
Coming soon